Peer Reviewed
Drug update
Long acting beta agonists and asthma
Recent articles on:
Breathing problems
Breathing problems
Abstract
These bronchodilators are a useful add-on therapy to inhaled corticosteroids for the treatment of persistent asthma.
Key Points
- Long acting beta agonists (LABAs) are a major therapeutic development in the management of asthma. They cause significant sustained bronchodilatation, thereby providing superior symptom control and improved lung function when added to inhaled corticosteroids.
Purchase the PDF version of this article
Already a subscriber? Login here.